Objective:To evaluate the clinical role of DNA microarray in detection of HBV genotpes and Lamivudine drug resistance test.

• 目的:评价基因芯片技术在乙型肝炎(乙肝)基因分型和拉米夫定耐药性检测中的临床价值。